Saracatinib is an efficacious clinical candidate for fibrodysplasia ossificans progressiva is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 72 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AR057374,HL007604
U.S. Department of Defense
Grant: MR140072
Innovative Medicines Initiative
Grant: 821600,875510
Wellcome
Grant: 106169/ZZ14/Z
NIAMS NIH HHS
Grant: R01 AR057374
NCATS NIH HHS
Grant: UG3 TR002617
The Francis Crick Institute
Grant: 10157
NHLBI NIH HHS
Grant: T32 HL007604
Wellcome Trust
Grant: 106169/Z/14/Z
Wellcome Trust
Grant: FC001157
FWCI
8.34
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals